IBS AG

  • WKN: 622840
  • ISIN: DE0006228406
  • Land: Deutschland

Nachricht vom 19.06.2012 | 18:29

DGAP-DD: IBS AG excellence, collaboration, manufacturing english



Notification concerning transactions by persons performing managerial
responsibilities pursuant to section 15a of the WpHG

Directors' Dealings notification transmitted by DGAP - a company of
EquityStory AG.
The person with duty of notification is solely responsible for the content
of this announcement.
---------------------------------------------------------------------------

Details of the person subject to the disclosure requirement
Last name: Schwickert
First name: Volker
Company: IBS AG excellence, collaboration, manufacturing

Position: Member of a managing body

Information about the transaction with duty of notification

Description of the financial instrument: Shares
ISIN/WKN of the financial instrument: DE0006228406
Type of transaction: Sale
Date: 30.03.2012
Price: 6.10
Currency: EUR
No. of items: 39600
Total amount traded: 241560.00
Place: over the counter

Explanation for publication:

Fulfilment of the conditions of the takeover bid submitted by Siemens
Industry Automation Holding AG, formally accepted by Mr. Schwickert, within
the scope of an over-the-counter-sale, as already announced in accordance
with §§ 10, 23, 27 of the German Securities Acquisition and Takeover Act
(WpÜG)

Information about the company with duty of publication

Issuer: IBS AG excellence, collaboration, manufacturing
Rathausstrasse 56
56203 Höhr-Grenzhausen
Deutschland
ISIN: DE0006228406
WKN: 622840


End of Directors' Dealings Notification 
(c) DGAP 19.06.2012

DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

ID 15478

Anleihe im Fokus

7,75% p.a. - Rendite aus Familienhand

– Zeichnungsstart: 23. Mai – Börse Frankfurt
– Zeichnung ab 1.000 Euro
– Laufzeit 5 Jahre
– WKN: A1TNA7
– 100% Rückzahlungskurs

GBC-Fokusbox

Syzygy AG: Aktie kaufen

Die nach den ersten drei Monaten des laufenden Jahres von Syzygy präsentierten Zahlen liegen im Rahmen unserer Erwartungen. Angesichts unserer unveränderten Prognosen behalten wir das bisherige Kursziel von 5 € bei und erneuern das Rating KAUFEN.

Event im Fokus

38. m:access Analystenkonferenz München

Datum: 06.06.2013
Zeit: 9:30 Uhr - 17.00 Uhr
Ort: Börse München



Aktuelle Research-Studie

Original-Research: getgoods.de Anleihe (von GBC AG): stark überdurchschnittlich attraktiv getgoods.de Anleihe

24. Mai 2013